发明名称 COPOLYMERS FOR SUPPRESSION OF AUTOIMMUNE DISEASES, AND METHODS OF USE
摘要 Random three- and four-amino acid copolymers having lengths of 14-,35- and 50- amino acid residues are provided. Fifty-mers of FEAK were effective inhibitors of MBP 85- 99 or proteolipid protein (PLP) 40-60-specific HLA-DR-2-restricted T cell clones. These copolymers efficiently suppressed EAE induced in susceptible SJL/J (H-2?s~) strain of mice with either whole spinal cord homogenate (WSCH) or with the encephalitogenic epitope PLP 139-151. YFAK 50-mer having a molar ratio of about y 0.8:F 0.2 inhibited binding of biotinylated MBP 85-99 epitope to HLA-DR-2 molecules more efficiently than either unlabeled MBP 85-99 or Copaxone$m(3). YFAK and FAK copolymers efficiently suppressed EAE induced in SJL/J (H-2?s~) mice with the encephalitogenic epitope PLP 139-151. Copolymers YFK, VYAK and tryptophan- containing VWAK were efficacious in alleviating severity and duration of symptoms of EAE induced by MBP 85-99, in a humanized mouse model expressing genes for both an HLA-DR-2 linked to multiple sclerosis (MS) in humans and for a T cell receptor from an MS patient.
申请公布号 CA2614171(A1) 申请公布日期 2003.04.10
申请号 CA20022614171 申请日期 2002.10.03
申请人 PRESIDENT AND FELLOWS OF HARVARD COLLEGE 发明人 FRIDKIS-HARELI, MASHI;STROMINGER, JACK L.
分类号 C08G69/10;A61K38/16;A61K45/06;A61P3/10;A61P19/02;A61P25/00;A61P37/06;C07K1/00;C07K2/00;C07K4/00;C07K7/00;C07K7/06;C07K14/00;C08G69/06;C08G69/48 主分类号 C08G69/10
代理机构 代理人
主权项
地址